← Human Trials & Peer-Reviewed Studies
Nutritional Supplement "Bao Khi Khang" as an Adjuvant Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Plain-language guide to PMID 29683370 (2018): open-label randomized controlled trial of Copper (Supplement) in 60 patients.
Key Facts
- PMID
- 29683370
- Journal
- Journal of medicinal food
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Hoang BX et al. (4 authors)
- DOI
- 10.1089/jmf.2017.0115
What This Study Did, in Plain Language
What Was Tested
Researchers studied Copper (Supplement) in this randomized controlled trial publication.
This was a prospective, randomized, open-label controlled trial in 60 patients presenting with acute exacerbation of COPD.
The treatment outcomes, including clinical and paraclinical parameters of exacerbation of COPD, were compared between the experimental group and the control group at day 15 and 30.
Who Took Part
The study group was 60 patients.
By PubMed's age tags, the people studied were adults, middle-aged adults and older adults, both men and women.
Patients were randomized into two groups, the control and the experimental groups.
The experimental group was treated with Bao Khi Khang tablets combined with the standard therapeutic protocol.
How the Study Was Run
The researchers set it up as a randomized and open-label study.
Because people in this Copper (Supplement) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Nothing was hidden in this open-label Copper (Supplement) study: the patients and staff both knew the treatment.
The control group was treated with the standard therapeutic protocol (Antimicrobial+Corticosteroids+Bronchodilator+Mucolytic drugs).
What Was Measured
The treatment outcomes, including clinical and paraclinical parameters of exacerbation of COPD, were compared between the experimental group and the control group at day 15 and 30.
PubMed files the paper under topics including Cough, Dietary Supplements, Plant Extracts and Pulmonary Disease, Chronic Obstructive.
The authors tagged it with the keywords Bao Khi Khang, COPD, chronic obstructive pulmonary disease, herbal medicine, nutritional supplement and phytotherapy.
What This Means in Plain Language
The paper is a randomized and open-label study of Copper (Supplement) in 60 patients.
The publication is from 2018 (Journal of medicinal food), a journal based in United States.
More context: the Copper (Supplement) compound page, all human trials.
Our Notes on the Compound
Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.